Number of Shares
624,120.00
Current Holdings Value*
$39.83 Mil
% of Portfolio
1.32%
Total Estimate Gain
$70.28 Mil
% of Total Estimate Gain
145.21%

JPMorgan Small Cap Growth Fund's Halozyme Therapeutics Inc Holding Summary

As of 2025-03-31, JPMORGAN TRUST II held 624,120.00 shares of Halozyme Therapeutics Inc(HALO), totaling $39.83 Mil. This investment constitutes 1.32% of their stock portfolio, and JPMORGAN TRUST II now holds 0.51% of the outstanding Halozyme Therapeutics Inc(HALO) stock.

The initial trade took place in 2019Q3. And since then JPMorgan Small Cap Growth Fund has made 6 purchases of HALO, at an average price of $19.33, for a total of 2.50 Mil shares. In addition, there have been 15 sales at an average price of $44.02 for 1.88 Mil shares. Based on historical transaction data and HALO's current price of $57.54, JPMorgan Small Cap Growth Fund's estimated gain on his HALO holdings is $70.28 Mil, reflecting a 145.21% gain to date.

JPMorgan Small Cap Growth Fund HALO ($57.54) Holding Chart

JPMorgan Small Cap Growth Fund HALO ($57.54) Quarterly Buys and Sells

Period Bought/Sold (Sh.) % Change Qtr. End Shares Avrg. Price
Shares Bought 0 Average Price $-/Share
Shares Sold 0 Average Price $-/Share
Current Price $0.00 Total Estimated Gain 0 %

Top Ranked Articles

  • 1